PepperLime Health Acquisition - Warrants (01/10/2026)'s EBIT is $-1.4M, above the sector sector average of $-63M.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023
The latest EBIT for PEPLW is $-1.4M as of September 2023. That compares with $-1.3M in the prior-year period — down 9.2% year over year. That is above the sector sector average of $-63M. Investors often review this figure alongside PepperLime Health Acquisition - Warrants (01/10/2026)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, PEPLW's EBIT moved from $-1.3M to $-1.4M — a 9.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PepperLime Health Acquisition - Warrants (01/10/2026)'s operating scale or balance-sheet position.
Against its sector companies, PEPLW currently prints $-1.4M for EBIT, while the sector average sits near $-63M. That is roughly 97.8% above the sector mean. Large gaps often invite a closer look at PepperLime Health Acquisition - Warrants (01/10/2026)'s growth, margins, and balance sheet.
A EBIT figure of $-1.4M for PEPLW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-63M. Explore the charts below for those layers of context.
After noting PEPLW's EBIT ($-1.4M), review year-over-year change from $-1.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.